Literature DB >> 10715517

Biochemical analysis of HLA class I subunits expression in breast cancer tissues.

M P Pistillo1, G Nicolò, S Salvi, P Capanni, L Perdelli, G Pasciucco, G B Ferrara.   

Abstract

The expression of HLA class I alpha-chain and beta(2)-m subunits was studied at the protein level by a semiquantitative Western blot (WB) approach, in 25 primary breast tumors. The results indicated three pathways of alterations defined comparing the tumor WB gel band with the corresponding PBL gel band: (i) high downregulation pattern (the tumor WB gel band was < or =50% relative to the PBL band), which was found in 44% and 36% of tumors for alpha-chain and beta(2)-m, respectively; (ii) low downregulation pattern (the tumor gel band was between 51% and 75%), which was found in 24% and 20% of tumors for alpha-chain and beta(2)75%), which was found in 32% and 44% of tumors for alpha-chain and beta(2)-m, respectively. The concordance rate with immunohistochemistry (IHC) performed on the same tissue samples was 72% for alpha-chain and 64% for beta(2)-m. This study shows that the use of a semiquantitative WB technique can well define the levels of HLA class I antigens in an autologous setting allowing the biochemical analysis of HLA class I downregulation directly in solid tumor tissues. In addition, the WB technique can be a valuable tool to objectively support the IHC method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715517     DOI: 10.1016/s0198-8859(99)00179-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.

Authors:  Majid Mahmoodi; Hedayat Nahvi; Mahdi Mahmoudi; Amir Kasaian; Mohammad-Ali Mohagheghi; Kouros Divsalar; Bijan Nahavandian; Abbas Jafari; Bita Ansarpour; Batoul Moradi; Asghar Aghamohammadi; Aliakbar Amirzargar
Journal:  Pathol Oncol Res       Date:  2011-07-01       Impact factor: 3.201

3.  Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma.

Authors:  Kazushige Koike; Hironari Dehari; Shota Shimizu; Koyo Nishiyama; Tomoko Sonoda; Kazuhiro Ogi; Junichi Kobayashi; Takanori Sasaki; Takashi Sasaya; Kei Tsuchihashi; Tomohide Tsukahara; Tadashi Hasegawa; Toshihiko Torigoe; Hiroyoshi Hiratsuka; Akihiro Miyazaki
Journal:  Cancer Sci       Date:  2020-04-15       Impact factor: 6.716

4.  Immunophenotyping of the cluster of differentiation 74, migration inhibitory factor, and cluster of differentiation 44 expression on human breast cancer-derived cell lines.

Authors:  Hussain Al Ssadh; Waleed Al Abdulmonem
Journal:  Int J Health Sci (Qassim)       Date:  2019 Mar-Apr

Review 5.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

6.  Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis.

Authors:  Xin Chen; Na Sun; Rongqin Li; Xuejia Sang; Xueqin Li; Jie Zhao; Jing Han; Jing Yang; Takayuki Ikezoe
Journal:  Int J Biol Sci       Date:  2021-03-25       Impact factor: 6.580

Review 7.  Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.

Authors:  Karthik Dhatchinamoorthy; Jeff D Colbert; Kenneth L Rock
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

8.  Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer.

Authors:  Gisela Bevilacqua Rolfsen Ferreira da Silva; Tarsia Giabardo Alves Silva; Roberta Aparecida Duarte; Nicolino Lia Neto; Hélio Humberto Angotti Carrara; Eduardo Antônio Donadi; Maria Alice Guimarães Gonçalves; Edson Garcia Soares; Christiane Pienna Soares
Journal:  Int J Breast Cancer       Date:  2013-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.